4//SEC Filing
Cranston Lynda Sarah 4
Accession 0001213900-17-010210
CIK 0001498382other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 7:52 PM ET
Size
5.0 KB
Accession
0001213900-17-010210
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Other
Common Stock
2017-09-29$3.20/sh+71$227→ 2,486 total(indirect: Note)
Footnotes (2)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- [F2]Shares are held by J.G. Cranston & Associates, Inc.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001633660
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 7:52 PM ET
- Size
- 5.0 KB